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It has often been asserted that Australian marsupial species are particularly susceptible to Toxoplasma
gondii infection and to clinical toxoplasmosis following infection. This implicates T. gondii as a potential
threat to marsupial population viability, and contrasts to what is known of T. gondii in populations of
several other host species. We reviewed the literature, and found a lack of scientiﬁcally robust evidence
addressing the occurrence of T. gondii infection in free-ranging populations of Australian marsupial
species, and the impacts of the infection on population health. Key limitations included a lack of studies
in free-ranging marsupial populations, study ﬁndings susceptible to substantial chance inﬂuences, and
selection, misclassiﬁcation and confounding biases. The lack of scientiﬁcally robust data available on this
topic indicates that assertions that free-ranging populations of Australian marsupials are particularly
susceptible to T. gondii infection and to toxoplasmosis are premature. The threat of T. gondii to the
viability of free-ranging marsupial populations should therefore be regarded, at this stage, as a
hypothesis.
© 2015 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Australia is home to a vast array of endemic marsupial species
(superorder Australidelphia). Of an estimated 162 marsupial spe-
cies present at the time of European settlement in 1788, twelve
species have since become extinct, and many others have suffered
major contraction of distribution and substantial to severe popu-
lation declines (Burbidge et al., 2009; Woinarski, 2015). The pri-
mary drivers of these population declines are believed to be:
anthropogenic habitat loss; habitat destruction associated with
climate change, altered ﬁre regimes and the introduction of
competing feral herbivores and exotic weeds; and predation by
introduced feral species, particularly foxes and cats (Dickman,
1996; Fisher et al., 2003; McKenzie et al., 2007; Burbidge et al.,
2009; Saunders et al., 2010).
There has also been speculation as to the role of introduced
infectious disease as a contributing factor to population declines of
Australian marsupials (e.g., Freeland, 1994; Abbott, 2006;
Thompson et al., 2010).
Toxoplasma gondii is arguably the most broadly implicated
infection, prompted by reports of cases and outbreaks of severe
clinical toxoplasmosis in captive populations of Australian marsu-
pial species. From the published literature, there appears to be a
perception that marsupials are particularly susceptible to infection
with T. gondii and to toxoplasmosis. For example: “Toxoplasmosis is
a signiﬁcant disease of Australian marsupials commonly causing
mortality in captive and free-ranging populations…” (Obendorf
et al., 1996); “Marsupials and new world monkeys are among the
most susceptible animals for developing the clinical disease toxo-
plasmosis…” (Skerratt et al., 1997); “Australasian marsupials,
especially wallabies, are highly susceptible to acute toxoplasmosis”
(Dubey and Crutchley, 2008); “Australianmarsupials are among the
most susceptible hosts for T. gondii…” (Parameswaran et al.,
2009a); “T. gondii is of concern for Australian native marsupials,
which appear to be particularly susceptible to acute infection…”
(Hollings et al., 2013).
In this paper, we examine the evidence for these assertions. We
review estimates of the frequency of T. gondii infection in free-
ranging Australian marsupial populations, and then review the
extent to which the infections are associated with acute toxoplas-
mosis or with other effects (such as behavioural changes and
reduced reproductive success) that may threaten population
viability.
1.1. T. gondii infection and toxoplasmosis
T. gondii is a protozoan parasite, which can infect awide range of
endothermic vertebrates. Cats (Felidae) are the deﬁnitive host-
infected cats shed environmentally resistant oocysts in the faeces.
Oocysts become infective in the environment, and if ingested can
infect both intermediate hosts (including Australian marsupial
species) and other deﬁnitive hosts. Following ingestion, sporozoites
excyst from oocysts, invade the gut epithelium and transform into
tachyzoites. Tachyzoites multiply asexually and may colonise many
host tissues, evoking a strong immune response. Tachyzoites
differentiate into bradyzoites, which produce tissue cysts that are
resistant to the immune response. Bradyzoites may be transmitted
to a deﬁnitive host, or another intermediate host, upon ingestion of
infected tissues. In addition, these hosts may also be infected via
vertical transmission from infected mother to foetus/suckling
young (Dubey, 1998, 2010).
In most intermediate host species, including people, T. gondii
infection tends to be subclinical; toxoplasmosis (clinical disease
caused by T. gondii infection) is usually associated with compli-
cating factors such as immunosuppression (Montoya andLeisenfeld, 2004; Dubey, 2010). Clinical toxoplasmosis may follow
recent infection with T. gondii, or result from a recrudescent
infection. Recrudescence may be prompted by concurrent illness or
immunosuppression (Ruskin and Remington, 1976; Lappin et al.,
1991; Nicoll et al., 1997).
2. The frequency of T. gondii infection in free-ranging
populations of Australian marsupial species
No published studies have investigated the incidence of T. gondii
infection in free-ranging populations of Australian marsupials.
Surveys have provided estimates infection prevalence and sero-
prevalence; these are summarised in Tables 1 and 2.
2.1. T. gondii infection surveys undertaken in free-ranging
populations of Australian marsupials
Evidence of T. gondii infection has been found in free-ranging
populations of red kangaroos (Macropus rufus), western grey kan-
garoos (Macropus fuliginosus), common wallaroos (Marcopus
robustus) and woylies (Bettongia penicillata) (Table 1). Findings
suggestive of T. gondii infection (histopathological evidence
without conﬁrmatory testing) have also been obtained from long
nosed bandicoots (Perameles nasuta), eastern barred bandicoots
(Perameles gunnii), southern brown bandicoots/quenda (Isoodon
obesulus), quokka (Setonix brachyurus), brushtail possums (Tricho-
surus vulpecula), brush-tailed phascogales (Phascogale tapoatafa)
and kowari (Dasyuroides byrnie) (Table 1).
Prevalence estimates are all limited by uncertain external val-
idity, due to the use of non-proportionate sampling methods:
reliance on culled animals, road kill or trapping for study subjects
may entail selection bias. Surveys involving small sample sizes have
low power to detect the presence of infection, and marked
imprecision in prevalence estimates (Table 1). Commonly, the use
of diagnostic methodology that is known to be of poor sensitivity
and/or speciﬁcity in other species leaves apparent prevalence es-
timates subject to misclassiﬁcation bias.
In marsupial surveys, the most commonly used diagnostic test
has been the mouse bioassay, which lacks sensitivity (Piergili
Fioretti, 2004). None of the surveys of Australian marsupials us-
ing this technique also used immunohistochemistry or PCR to
conﬁrm identiﬁcation of T. gondii bradyzoites. Thus, the speciﬁcity
of the mouse bioassay may be compromised, as T. gondii brady-
zoites can appear very similar to those of Neospora caninum under
light microscopy (Dubey et al., 2009). As with the mouse bioassay,
sample inoculation into cell culture (in this case 13-day old chick
embryos (Table 1)) lacks sensitivity, often because of laboratory
error (Piergili Fioretti, 2004).
Histopathological examination of host tissues, without conﬁr-
matory immunohistochemistry or PCR, was used in a number of
marsupial surveys (Table 1). However, this is also an insensitive
screening tool, particularly in identifying low burden T. gondii in-
fections (Piergili Fioretti, 2004). Speciﬁcity of these results might
also be compromised by misidentiﬁcation of other protozoan par-
asites as T. gondii (Dubey et al., 2009).
PCR ampliﬁcation of T. gondii DNA in tissue samples is generally
considered a sensitive indicator of infection (Burg et al., 1989; Su
et al., 2010). PCR has only been used in two surveys of Australian
marsupials, which collectively sampled four species
(Parameswaran et al., 2010; Pan et al., 2012). A high proportion
these animals tested positive for T. gondii by this methodology.
Though these ﬁndings are limited by small sample sizes, they
sharply contrast to collective ﬁndings of similar species surveyed
histopathologically, where infection was rarely identiﬁed (Table 1).
As the latter studies were based on different species in different
Table 1
Toxoplasma gondii infection surveys undertaken in free-ranging populations of Australian marsupial species. Except where noted, no prior clinical suspicion of toxoplasmosis
existed in sampled animals.
Species Study location (study) Sampling
timeframe
Diagnostic testa No.
infected/
no. tested
(%)
95% CIb
Eastern grey kangaroo
(Macropus giganteus)
Roma, Queensland (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/4 (0%) 0
e52.2%
Eastern grey kangaroo Blackall, Queensland (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/3 (0%) 0
e60.2%
Western grey kangaroo
(M. fuliginosus)
Menzies, Western Australia (Pan
et al., 2012)
2008 PCR (heart, liver, lung, spleen, diaphragm) 5/5 (100%) 54.1
e99.6%
Western grey
kangaroo-adults
Perth, Western Australia
(Parameswaran et al., 2010)
Not
speciﬁed
PCR (brain and tongue) 9/12 (75%) 46.2
e90.9%
Western grey
kangaroo-pouch
young
Perth, Western Australia
(Parameswaran et al., 2010)
Not
speciﬁed
PCR (brain, heart, skeletal muscle, liver, lung, small intestine, kidney and
spleen)
2/17
(11.8%)
3.6
e34.7%
Common wallaroo
(M. robustus)
Blackall, Queensland (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/5 (0%) 0
e45.9%
Common wallaroo Kynuna, Queensland (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/3 (0%) 0
e60.2%
Common wallaroo Menzies, Western Australia (Pan
et al., 2012)
2008 PCR (heart, liver, lung, spleen, diaphragm) 5/5 (100%) 54.1
e99.6%
Red kangaroo (M. rufus) Blackall, Queensland (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/5 (0%) 0
e45.9%
Red kangaroo Longreach, Queensland (Smith
and Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/6 (0%) 0
e41.0%
Red kangaroo Menzies, Western Australia (Pan
et al., 2012)
2008 PCR (heart, liver, lung, spleen, diaphragm) 6/6 (100%) 59.0
e99.6%
Woyliec (Bettongia
penicillata)
Manjimup, Western Australia
(Parameswaran et al., 2010)
Not
speciﬁed
PCR (brain and heart) 2/4 (50%) 14.7
e85.3%
Long-nosed potoroo
(Potorous tridactylus)
Winkleigh, Tasmania (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/1 (0%) 0
e84.2%
Quokka (Setonix
brachyurus)
Rottnest Island, Western
Australia (Gibb et al., 1966)
Nov 1961 Histopathology (left lateral femoral muscle biopsy) 4/92 (4.3%) 1.8
e10.6%
Nov 1963 14/20
(70%)
47.8
e85.4%
Jan 1964 1/20 (5%) 1.2
e23.8%
Feb 1964 6/18
(33.3%)
16.3
e56.6%
Quokkad Rottnest Island, Western
Australia (Gibb et al., 1966)
Nov 1963
eFeb 1964
Mouse bioassay (suspension of host skeletal muscle, þ/ liver, brain and
heart, injected IP and combined IP & IC; impression
smears ± histopathological examination of mice)
13-day old chick embryo inoculation (suspension of host skeletal muscle,
cardiac muscle and brain)
2/28 (7.1%) 2.2
e22.8%
Brushtail possum
(Trichosurus
vulpecula)
Brisbane, Queensland (Cook and
Pope, 1959)
Not
speciﬁed
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
2/7 (28.6%) 8.5
e65.1%
Brushtail possum Dalby, Queensland (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain or pooled organs, injected SC;
mouse brain emulsiﬁed and examined for T. gondii cysts)
0/3 (0%) 0
e60.2%
Brushtail possum Cressy, Tasmania (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain or pooled organs, injected SC;
mouse brain emulsiﬁed and examined for T. gondii cysts)
0/9 (0%) 0
e30.8%
Western Ringtail
possum
(Pseudocheirus
occidentalis)e
Western Australia
(Parameswaran, 2008)
Not
speciﬁed
PCR (heart of one possum, skeletal muscle of another) 0/2 (0%)
Brush-tailed
phascogale
(Phascogale
tapoatafa)
Burleigh, Queensland (Cook and
Pope, 1959)
Not
speciﬁed
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
1/1 (100%) 15.8
e98.7%
Eastern pygmy possum
(Cercartetus nanus)
Wilmot, Tasmania (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/1 (0%) 0
e84.2%
Southern brown
bandicoot (Isoodon
obesulus)
Brisbane & Innisfail, Queensland
(Cook and Pope, 1959)
Not
speciﬁed
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
5/10 (50%) 23.4
e76.6%
Southern brown
bandicoot
Brisbane, Queensland (Pope
et al., 1957a)
August 1955
eFebruary
1956
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
16/38
(42.1%)
27.8
e57.9%
Southern brown
bandicoot
Mt Glorius, Queensland (Pope
et al., 1957a)
August 1955
eFebruary
1956
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
0/2 (0%) 0
e70.8%
Southern brown
bandicoot
North Queensland (Pope et al.,
1957a)
August 1955
eFebruary
1956
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
1/3 (33.3%) 6.8
e80.6%
(continued on next page)
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Table 1 (continued )
Species Study location (study) Sampling
timeframe
Diagnostic testa No.
infected/
no. tested
(%)
95% CIb
Southern brown
bandicoot
Brisbane, Queensland (Pope
et al., 1957b)
1951 Histopathology (brain, lungs, liver, spleen, kidney, retroperitoneal lymph
node);
Mouse and guinea pig bioassays (suspension of host liver, spleen and brain
injected IP and IC; histopathological examination of mouse brain, heart,
lungs, spleen, skeletal muscle, kidneys, pancreas, blood)
1/1 (100%) 15.8
e98.7%
Long-nosed bandicoot
(Perameles nasuta)
Mt Glorius, Queensland (Pope
et al., 1957a)
August 1955
eFebruary
1956
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
1/2 (50%) 9.4
e90.6%
Long-nosed bandicoot Northern Queensland (Pope
et al., 1957a)
August 1955
eFebruary
1956
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
2/4 (50%) 14.7
e85.3%
Eastern barred
bandicoot (P. gunnii)
Longford, Tasmania (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/1 (0%) 0
e84.2%
Eastern barred
bandicootf
Tasmania (Obendorf et al., 1996) July 1992
eMarch
1995
Histopathology (brain, heart, lung and skeletal muscle) with serology 7/8 (87.5%) 51.8
e97.2%
Greater bilby (Macrotis
lagotis)
Birdsville, Queensland (Cook
and Pope, 1959)
Not
speciﬁed
Mouse bioassay (host brain suspension inoculated IC or host liver spleen,
kidney and lung suspension inoculated IP; if mouse necropsy was suggestive
of T. gondii infection, contact smear of brain performed)
0/1 (0%) 0
e84.2%
Tasmanian devil
(Sarcophilus harrisii)
Gladstone, Tasmania (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/3 (0%) 0
e60.2%
Eastern quoll (Dasyurus
viverrinus)
Gladstone, Tasmania (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/7 (0%) 0
e36.9%
Spotted-tailed quoll
(D. maculatus)
Wilmot, Tasmania (Smith and
Munday, 1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/1 (0%) 0
e84.2%
Northern quollg
(D. hallucatus)
Kakadu National Park, Northern
Territory (Oakwood and
Pritchard, 1999)
1993e1995 Histopathology (brain, heart, lungs, diaphragm, “gut”, liver, tongue, hindleg
muscle)
0/28 (0%) 0
e11.9%
Kowari (Dasyuroides
byrnie)
Queensland (Attwood et al.,
1975)
Not
speciﬁed
Histopathology (brain, spinal cord, heart, lung, kidney, adrenal gland,
stomach, “gut”, spleen, pancreas, parapancreatic node)
4/17
(23.5%)
9.7
e47.6%
Dusky Antechinus
(Antechinus
swainsonii)
Tasmania (Smith and Munday,
1965)
Not
speciﬁed
Mouse bioassay (suspension of host brain, þ/ liver, lung & spleen, injected
SC; mouse brain emulsiﬁed and examined for T. gondii cysts)
0/1 (0%) 0
e84.2%
Brown Antechinus
(A. stuartii)
Not speciﬁed (Attwood et al.,
1975)
Not
speciﬁed
Histopathology (brain, spinal cord, heart, lung, kidney, adrenal gland,
stomach, “gut”, spleen, pancreas, parapancreatic node)
0/3 (0%) 0
e60.2%
White-footed dunnart
(Sminthopsis
leucopus)
Not speciﬁed (Attwood et al.,
1975)
Not
speciﬁed
Histopathology (brain, spinal cord, heart, lung, kidney, adrenal gland,
stomach, “gut”, spleen, pancreas, parapancreatic node)
0/7 (0%) 0
e36.9%
a Regarding mouse bioassays-SC ¼ subcutaneous inoculation, IP ¼ intraperitoneal inoculation, IC ¼ intracerebral inoculation.
b Calculated by review author using Jeffrey's 95% conﬁdence interval.
c One (infected) woylie exhibited neurological symptoms prior to death.
d Survey undertaken in wild quokka with serological or histological evidence of T. gondii infection.
e Wild possums found with neurological symptoms.
f One bandicoot obtained via trap death-previously identiﬁed as seropositive for T. gondii; origin of the other bandicoots unclear.
g Study subjects obtained via roadkill.
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tribution of infection. However, such discordant results do lend
support to the hypothesis that histopathological surveys are
insensitive in estimating prevalence of infection in marsupial
populations showing no clinical signs of toxoplasmosis. PCR tech-
niques have been demonstrated to have high speciﬁcity (Burg et al.,
1989): given the use of appropriate negative controls and
sequencing in both studies, it seems unlikely that false positives
would have substantially inﬂuenced the ﬁndings of the PCR
surveys.2.2. T. gondii exposure in free-ranging populations of Australian
marsupials
T. gondii serosurveys have found T. gondii antibodies in pop-
ulations of western grey kangaroos, eastern grey kangaroos (Mac-
ropus giganteus), Bennett's wallabies (Macropus rufogriseus), bridled
nailtail wallabies (Onychogalea fraenata), Tasmanian pademelons
(Thylogale billardierii), brush tailed rock wallabies (Petrogale pen-
icillata), quokkas, woylies, Tasmanian devils (Sarcophilus harisii),common wombats (Vombatus ursinus), eastern quolls (Dasyurus
viverrinus), spotted-tail quolls (Dasyurus maculatus), chuditch (or
western quolls, Dasyurus geoffroii), brushtail possums, western
ringtail possums (Pseudocheirus occidentalis), southern brown
bandicoots, eastern barred bandicoots, long-nosed bandicoots and
bilbies (Macrotis lagotis) (Table 2).
Seroprevalence surveys are prone to limitations regarding
inferring infection prevalence, similar to those affecting surveys of
T. gondii. In particular, the potential inﬂuence of misclassiﬁcation is
an important consideration. While the use of serological surveys
avoids invasive tissue sampling (which usually necessitates
euthanasia or opportunistic sampling of otherwise dead animals in
wildlife populations), it is important that the serological test(s)
have been validated at the cut off titre used to differentiate infected
and non-infected animals, in the species being studied. Identifying
whether or not the serological test accurately reﬂects the infection
status of the tested host is essential in estimating the true preva-
lence of infection from apparent seroprevalence data. Very few
serological tests have been adequately validated for use in Austra-
lian marsupial species (Supplementary Tables 1e3).
Table 2
Toxoplasma gondii seroprevalence surveys undertaken in free-ranging populations of Australian marsupial species. Except where noted, animals were sampled or taken from
the wild via trapping or culls, and no prior clinical suspicion of toxoplasmosis existed in sampled animals.
Species Study location (study) Sampling
timeframe
Serological test (restrictions on
antibody type detected, if any)
Cut off for seropositivity
No. seropositive/
no. tested (%)
95% CI
Western grey kangaroo
(Macropus fuliginosus)
Perth, Western Australia (Parameswaran et al.,
2009a; Parameswaran, 2008)
May 2005eMay
2007
ELISA (IgG only)
OD 0.636a
34/219 (15.5%) 10.7
e20.3%
Eastern grey kangaroo
(M. giganteus)
Roma, Queensland (Parameswaran, 2008) 2004e2005 ELISA (IgG only)
OD 0.636a
0/112 (0%) 0e3.2%b
Eastern grey kangaroo Sydney, New SouthWales (Parameswaran, 2008) May 2006 ELISA (IgG only)
OD 0.636a
2/65 (3.1%) 0e7.3%
Macropus sppc Queensland (Cook and Pope, 1959) Not speciﬁed Complement ﬁxation test
Titre 1:8a
0/31 (36.7%)d 0
e10.9%b
Bennett's wallaby
(M. rufogriseus rufogriseus)
Tasmania (Munday, 1972) Not speciﬁed Sabin-Feldman dye test
Titre 1:16a
0/1 (0%) 0
e84.2%b
Bennett's wallaby Tasmaniaf (Johnson et al., 1988) Not speciﬁed ELISA (IgG only)
OD 0.25a
5/151 (3.3%) 1.5%
e7.5%b
Bennett's wallabyg Tasmaniac (Hollings et al., 2013) Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:64a
2/25 (8.0%) 2.4
e25.1%b
Tasmania pademelon
(Thylogale billardierii)
Tasmania (Munday, 1972) Not speciﬁed Sabin-Feldman dye test
Titre 1:16a
3/7 (42.9%) 15.7
e75.5%b
Tasmanian pademelon Tasmaniaf (Johnson et al., 1988) Not speciﬁed ELISA (IgG only)
OD 0.25a
15/85 (17.7%) 11.0
e27.1%b
Tasmanian pademelong Tasmania (Hollings et al., 2013) Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:64a
28/228 (12.3%) 8.6
e17.2%b
Bridled nailtail wallaby
(Onychogalea fraenata)
Taunton National Park, Queensland (Turni and
Smales, 2001)
1996 Latex agglutination test 6/39 (15.4%) 7.3
e29.8%b
Black footed rock wallaby
(Petrogale lateralis)
South Western Australia (Jakob-Hoff and
Dunsmore, 1983)
1979 Indirect haemagglutination inhibition
test
0/26 (0%) 0
e12.8%b
Brush tailed rock wallaby
(P. penicillata)
South east Queensland (Barnes et al., 2010) July 2004eAugust
2005
Modiﬁed agglutination test (not IgM)
Titre 1:40a
3/64 (4.7%) 1.7
e12.9%b
Banded hare wallabies
(Lagostrophus fasciatus)
Faure Island Sanctuary, Western Australia
(Parameswaran, 2008)
April 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/5 (0%) 0
e45.9%b
Spectacled hare wallabies
(L. conspicillatus)
Barrow Island, Western Australia
(Parameswaran, 2008)
September 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/3 (0%) 0
e60.2%b
Quokka (Setonix brachyurus) Rottnest, Western Australia (Gibb et al., 1966) 1964 Sabin-Feldman dye test
Titre >1:8e
13/37 (35.1%) 21.8
e51.4%b
Burrowing bettong/boodie
(Bettongia lesueur)
Faure Island Sanctuary, Western Australia
(Parameswaran, 2008)
April 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/28 (0%) 0
e11.9%b
Burrowing bettong/boodie Barrow Island, Western Australia
(Parameswaran, 2008)
September 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/14 (0%) 0
e21.8%b
Brush-tailed bettong/woylie
(B. penicillata)
Upper Warren region, Western Australia
(Parameswaran, 2008)
March 2006 Modiﬁed agglutination test (not IgM)
Titre 1:40a
9/153 (5.8%) 3.2
e10.8%b
Brush-tailed bettong/woylie Dryandra Nature Reserve, Western Australia
(Parameswaran, 2008)
Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/12 (0%) 0
e24.7%b
Brush-tailed bettong/woylie Batalling Forest, Western Australia
(Parameswaran, 2008)
Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/17 (0%) 0
e18.5%b
Brush-tailed bettong/woylie Tutanning Nature Reserve, Western Australia
(Parameswaran, 2008)
Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/8 (0%) 0
e33.6%b
Brush-tailed bettong/woylie Venus Bay Island, South Australia
(Parameswaran, 2008)
Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/14 (0%) 0
e21.8%b
Brush-tailed bettong/woylie St Peters Island, South Australia (Parameswaran,
2008)
Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:40a
1/73 (1.4%) 0.3
e7.3%b
Brushtail possum
(Trichosurus vulpecula)
Sydney (Eymann et al., 2006) Nov 2002eApril
2005
Modiﬁed agglutination test (not IgM)
Titre 1:25a
9/135 (6.3%) 3.6
e12.2%b
Brushtail possum Myall Lake National Park, New South Wales
(Eymann et al., 2006)
Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:25a
0/7 (0%) 0
e36.9%b
Brushtail possum Taronga Zoo grounds (non captive)-Sydney (Hill
et al., 2008)
Feb 2005eMay
2006
Modiﬁed agglutination test (not IgM)
Titre 1:25a
6/126 (4.8%) 2.2
e10.0%b
Brushtail possum Blue Mountains, New South Wales (Hill et al.,
2008)
Oct 2005 & May
2006
Modiﬁed agglutination test (not IgM)
Titre 1:25a
0/17 (0%) 0
e18.5%b
Brushtail possum Queensland (Cook and Pope, 1959) Not speciﬁed Complement ﬁxation test
Titre 1:8e
1/7 (14.3%)d 3.2
e52.7%b
Brushtail possum Tasmania (Hollings et al., 2013) Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:64a
0/14 (0%) 0
e21.8%b
Brushtail possumg Kangaroo Island (O'Callaghan and Moore, 1986) MarcheApril
1985
Indirect haemagglutination test 0/30 (0%) 0
e11.2%b
Brushtail possumh Western Australia (Clarke, 2011) 2006e2008 Direct agglutination test 0/95 (0%) 0e3.8%b
Modiﬁed agglutination test (not IgM) 0/95 (0%) 0e3.8%b
Brushtail possum Barrow Island, Western Australia
(Parameswaran, 2008)
September 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/6 (0%) 0
e41.0%b
Ringtail possum
(Pseudocheirus convolutor)
Tasmania (Munday, 1972) Not speciﬁed Sabin-Feldman dye test
Titre 1:16a
0/3 (0%) 0
e60.2%b
Western ringtail possum
(P. occidentalis)h
Western Australia (Clarke, 2011) 2006e2008 Direct agglutination test
Titre 1:64e
2/99 (2.0%) 0.6
e7.0%b
(continued on next page)
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Table 2 (continued )
Species Study location (study) Sampling
timeframe
Serological test (restrictions on
antibody type detected, if any)
Cut off for seropositivity
No. seropositive/
no. tested (%)
95% CI
Modiﬁed agglutination test (not IgM) 0/99 (0%) 0e3.6%b
Common planigale (Planigale
maculata)
Barrow Island, Western Australia
(Parameswaran, 2008)
September 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/5 (0%) 0
e45.9%b
Common wombat (Vombatus
ursinus)
Southern Tablelands, New South Wales (Hartley
and English, 2005)
3/8/2001e25/2/
2002
Latex agglutination test
Titre 1:32a
1/23 (4.35%) 1.0
e21.1%b
Direct agglutination test
Titre >1:64a
6/23 (26.1%) 12.6
e46.7%b
Modiﬁed agglutination test (not IgM)
Titre >1:64a
6/23 (26.1%) 12.6
e46.7%b
Southern brown bandicoot
(Isoodon obesulus)
southern Western Australia (Jakob-Hoff and
Dunsmore, 1983)
1979 Indirect haemagglutination inhibition
test
0/3 (0%) 0.0
e60.2%b
Southern brown bandicoot Queensland (Cook and Pope, 1959) Not speciﬁed Complement ﬁxation test
Titre 1:8a
35/89 (39.3%)d 29.8
e49.7%b
Southern brown bandicoot Brisbane (Pope et al., 1957a) Feb 1951 Complement ﬁxation test
Titre 1:8e
1/1 (100%) 15.8
e98.7%b
Southern brown bandicoot Brisbane, North Qld, Mt Glorius-Queensland
(Pope et al., 1957a)
August 1955
eFebruary 1956
Complement ﬁxation test
Titre 1:8e
15/35 (42.9%)d 27.9
e59.2%b
Golden bandicoots (I. auratus) Barrow Island, Western Australia
(Parameswaran, 2008)
September 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/11 (0%) 0
e26.5%b
Eastern barred bandicoot
(Perameles gunnii)
Huon Valley, Tasmania (Obendorf et al., 1996) July 1992eMarch
1995
Direct agglutination test and modiﬁed
agglutination testi
Both titres 1:64a
10/150 (6.7%)j,k 3.7
e11.8%b
Western barred bandicoot
(P. bougainville)
Faure Island Sanctuary, Western Australia
(Parameswaran, 2008)
April 2007 Modiﬁed agglutination test (not IgM)
Titre 1:40a
0/2 (0%) 0
e70.8%b
Long-nosed bandicoot
(P. nasuta)
Queensland (Pope et al., 1957a) August 1955
eFebruary 1956
Complement ﬁxation test
Titre 1:8e
1/1 (100%) 15.8
e98.7%b
Long-nosed bandicoot Queensland (Cook and Pope, 1959) Not speciﬁed Complement ﬁxation test
Titre 1:8a
2/7 (28.6%) 8.5
e65.1%b
Greater bilby (Macrotis
lagotis)
Queensland (Cook and Pope, 1959) Not speciﬁed Complement ﬁxation test
Titre 1:8a
0/1 (0%) 0
e84.2%b
Northern quollg (Dasyurus
hallucatus)
Kakadu National Park, Northern Territory
(Oakwood and Pritchard, 1999)
Feb 1993eMay
1995
Latex agglutination test 0/22 (0%)l 0
e14.8%b
Eastern quoll (D. viverrinus) Cradoc & Judbury, Tasmania (Fancourt et al.,
2014)
May 2011eJuly
2013
Modiﬁed Agglutination Test (not IgM)
Titre 1:64a
Ranged from 77.3%
to 100%m
Eastern quoll Bruny Island, Tasmania (Fancourt et al., 2014) May 2011
eSeptember 2013
Modiﬁed Agglutination Test (not IgM)
Titre 1:64a
Ranged from 9.4 to
29.4%m
Eastern quoll Tasmania (Hollings et al., 2013) Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:64a
13n/24 (54.2%) 34.9
e72.2%b
Spotted-tailed quolls
(D. maculatus)
Tasmania (Hollings et al., 2013) Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:64a
5n/7 (71.4%) 34.9
e91.5%b
Western quoll/chuditch
(D. geoffroii)
Batalling Forest, Western Australia (Haigh et al.,
1994)
Not speciﬁed Latex agglutination test 2/17 (11.8%) 3.6
e34.7%b
Western quoll/chuditch Julimar state forest, Western Australia
(Parameswaran, 2008)
June 2007 Modiﬁed Agglutination test (not IgM)
Titre 1:40a
3/23 (13.0%) 0
e26.8%
Tasmanian devil (Sarcophilus
harisii)
Tasmaniac (Hollings et al., 2013) Not speciﬁed Modiﬁed agglutination test (not IgM)
Titre 1:64a
6n/18 (33.3%) 16.3
e56.6%b
a Cut off for seropositivity nominated by study authors.
b Calculated by review author using Jeffrey's 95% conﬁdence interval.
c Seven red kangaroos (Macropus rufus) and 42 grey kangaroos (M. giganteus) sampled. Data as to which species the excluded anticomplementary sera were from was not
reported.
d Anti-complementary sera excluded from results-18 macropod sera (Cook and Pope, 1959); one common brushtail possum serum (Cook and Pope, 1959); 35 southern
brown bandicoot sera (Cook and Pope, 1959); two southern brown bandicoot sera (Pope et al., 1957a,b).
e Cut off applied to presented data post hoc by review authors.
f Pooled data from various locations in Tasmania.
g Some or all samples obtained via roadkill.
h Many possums were sampled on multiple occasions-if any individual tested positive at any time, it was included as ‘positive’; all possums that tested negative on all
occasions were included as ‘negative’.
i DAT titre <64 and no reaction on MAT classed as negative serological result; DAT 64 and no reaction on MAT classed as suspicious serological result; DAT andMAT titres
both 64 classed as positive serological result.
j A further 7/150 (4.7%) had ‘suspicious’ reactions.
k One seropositive bandicoot appeared to have neurological symptoms when subsequently retrapped (unclear whether this was a blinded observation); one seropositive
bandicoot found dead in trap on retrapping, and had histopathological evidence of T. gondii infection.
l Two quolls had very low serological reactions (1:2 and 1:3) that the study authors thought were probably insigniﬁcant. Neither of these quolls had histological evidence of
Toxoplasma gondii infection.
m Cohort study-seroprevalence measured approximately every second month.
n Estimated from graph in reference.
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data to estimate infection prevalence include: 1) an antibody
response may reﬂect exposure to an infection, but not necessarily
establishment of infection in the host; 2) if the sampled animal isacutely infected, it may not yet have a detectable antibody titre; 3)
if an infected animal has developed an IgM titre, but not yet IgG,
serological tests that do not detect T. gondii IgM antibodies (eg the
modiﬁed agglutination test, or some ELISAs) will not classify these
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infections, serological antibody titres may drop to levels that are
below the cut off titre for differentiating infected vs uninfected
animals, compromising sensitivity ewaning serological titres have
been demonstrated in chuditch (Haigh et al., 1994), brushtail pos-
sums (Eymann et al., 2006), woylies (A. Worth, Murdoch Univer-
sity-unpublished results) and in eastern grey kangaroos clinically
suspected of T. gondii infection (Miller et al., 2003); 5) non-speciﬁc
agglutination, which is known to occur with the direct agglutina-
tion test in other species (Dubey, 2010), may compromise test
speciﬁcity; 6) anti-complementary sera require exclusion from
serosurveys that use the complement ﬁxation test, which may bias
ﬁndings (e.g., Pope et al., 1957a; Cook and Pope, 1959); and 7) the
complement ﬁxation test, the Sabin Feldman dye test and ELISAs
require species-speciﬁc reagents. ELISAs used in marsupial surveys
were developed for use in the species involved. However, in studies
where the Sabin-Feldman dye test or complement ﬁxation test
were used, there was no description of the test being adapted for
the marsupial species surveyed (Pope et al., 1957a; Cook and Pope,
1959; Gibb et al., 1966; Munday, 1972).
2.3. Prevalence data as a measure of infection frequency
Beyond the potential impact of misclassiﬁcation and sample size
on inferring infection prevalences from apparent prevalences/
seroprevalences obtained via surveys, prevalence data are prone to
substantial limitations as a measure of infection frequency,
including in Australian marsupial species.
When infection is stable in a population, prevalence approxi-
mates the product of the incidence of infection, and mean duration
of infection. Many surveys identiﬁed low apparent prevalences or
seroprevalences. If not impacted bymisclassiﬁcation, these ﬁndings
could reﬂect T. gondii infection being relatively uncommon in the
surveyed populations. Alternatively, they may be consistent with
T. gondii infection being relatively common but associated with
high short term mortality rates in these populations, resulting in
infected animals having a low probability of inclusion in prevalence
surveys.
Conversely, high prevalence/seroprevalence of T. gondii infec-
tion has been identiﬁed in some marsupial populations, including
those subject to culls due to overpopulation. If not impacted by
misclassiﬁcation, such ﬁndings suggest, but do not provide
conclusive evidence, that T. gondii infection does not substantially
impact population viability. It has been postulated that other fac-
tors, particularly concurrent stressors, may interact with T. gondii
infection to produce adverse outcomes (e.g., Obendorf andMunday,
1983; Johnson et al., 1988; Miller et al., 2000). A high prevalence of
T. gondii infection in a stable population may therefore suggest that
the population could be at risk of disastrous population impacts, if
the population is subject to such factors.
3. Frequency of disease (toxoplasmosis) following infection
with T. gondii in free-ranging populations of Australian
marsupial species
Cats were introduced into Australia from Europe in the 1800s
(Denny and Dickman, 2010). It is thus assumed that the introduc-
tion and spread of T. gondii across Australia commenced around this
time. This presumptive short history of exposure to T. gondii
infection has been widely suggested to have resulted in increased
virulence and pathogenicity of T. gondii in Australian marsupial
species, compared to other intermediate hosts worldwide (Johnson
et al., 1988; Canﬁeld et al., 1990; Lynch et al., 1993; Reddacliff et al.,
1993; Obendorf et al., 1996; Barrows, 2006; Eymann et al., 2006;
Adkesson et al., 2007; Hollings et al., 2013). However, there is noevidence available to support this claim, and there is no reason to
assume that the virulence of a parasite will always be greater in
new host species (Ebert and Herre, 1996).
It has also been suggested that various stressors may be relevant
in the clinical manifestation of T. gondii infections-both acute and
recrudescent-in marsupials (Obendorf and Munday, 1983; Johnson
et al., 1988; Miller et al., 2000; Parameswaran et al., 2010; Fancourt
et al., 2014), although there are no published explorations of this
hypothesis. Some reports of toxoplasmosis amongst captive
marsupial populations have noted exposure to potential stressors
prior to the occurrence of disease. For example, immediately prior
to an outbreak associated with high mortality, a population of
captive sugar gliders (Petaurus breviceps) was exposed to repeated
episodes of social disruption, suboptimal nutrition and suboptimal
temperature (Barrows, 2006). Other cases or outbreaks of toxo-
plasmosis in captive wallabies have occurred following relocations
(Wilhelmsen and Montali, 1980; Dubey and Crutchley, 2008;
Bermundez et al., 2009) or social isolation (Adkesson et al., 2007).
A study of T. gondii infection in dasyurids (65 wild-caught, 103
laboratory reared), using histopathology without conﬁrmatory
testing, found the widest dissemination of organisms consistent
with T. gondii in two fat-tailed false antechinus (Pseudantechinus
macdonnellensis) with leukaemia (Attwood and Woolley, 1973).
3.1. Longitudinal studies of the population effects of T. gondii in
free-ranging populations of Australian marsupials
Cohort studies are the method of choice for comparing surviv-
ability in infected vs uninfected marsupial hosts, but are difﬁcult to
complete to an acceptable standard in free-ranging populations.
Key challenges include: 1) the vast resources required to precisely
follow up cohorts of a statistically adequate sample size; 2) the high
susceptibility of wildlife cohorts to bias, particularly due to loss to
follow-up, and when considering survivability, the typical
requirement for a proxy for death (such as failure to retrap) which
cannot differentiate the outcome from loss to follow-up; 3) inter-
mittent surveillance of wildlife cohorts (to monitor exposure and
outcome status) entails a low probability of sampling infected an-
imals that die acutely of toxoplasmosis, and the seropositive cohort
is thereforemore likely to involve animals that survivewith chronic
infection than those which succumb to acute infection; and 4)
putative confounding factors, such as age, can be very difﬁcult to
accurately measure in wild animals, and therefore accurately ac-
count for in statistical analyses, leaving study ﬁndings prone to
confounding.
These challenges likely explain why only two such studies have
been undertaken thus far. The ﬁrst was on eastern barred bandi-
coots at two sites in southern Tasmania's Huon Valley. Sites were
trapped every three months between July 1992 and March 1995.
One hundred and ﬁfty bandicoots were trapped over the period.
Both the direct agglutination test (without 2-mercaptoethanol)
(DAT) and modiﬁed agglutination test (that includes 2-mercap-
toethanol) (MAT) were used. One hundred and thirty three ban-
dicoots were negative on both serological tests, and 68% of these
were recaptured at least once. Ten bandicoots were positive on both
the MAT and DAT (both titres 64); ﬁve were not retrapped, while
ﬁve had antibodies on two consecutive occasions (three months
apart) and were not recaptured subsequently (Obendorf et al.,
1996). These ﬁndings may reﬂect reduced survival times in
eastern barred bandicoots infected with T. gondii, but there are
substantial limitations in drawing such a conclusion. The general-
ities listed above apply, and lack of validation of the diagnostic test
used is a potential inﬂuence on ﬁndings. Additionally, the small
seropositive cohort size means that chance effects on the results
cannot be conﬁdently excluded, and confounding (by age, in
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infection has been demonstrated to increase with age in other
species (Dubey, 2010). A further seven bandicoots tested positive on
the direct agglutination test (titre 64) in this study, but were
negative on the modiﬁed agglutination test (titre <64); none of
these seven bandicoots were recaptured (Obendorf et al., 1996).
Again, while this may reﬂect a lower survival time in bandicoots
acutely infected with T. gondii, this is not sufﬁcient evidence to
draw such a conclusion. The direct agglutination test has not been
validated in eastern barred bandicoots, and it is known to have
relatively poor speciﬁcity in other species (Dubey, 2010). Therefore,
misclassiﬁcation cannot be excluded, along with chance effects due
to the small sample size.
The second study was undertaken in eastern quolls in Tasmania.
Survival times of eastern quolls that were seropositive for T. gondii
were compared to those that were seronegative, in a locationwhere
the quoll populationwas classiﬁed as ‘stable’ (Bruny Island) across a
period of 2 years and 4 months. There was no evidence of a dif-
ference in survival time between seropositive and seronegative
quolls (Fancourt et al., 2014). However, a lack of power cannot be
excluded as an inﬂuence on study ﬁndings, due to the relatively
small sample size involved. Regarding the use of these data to
compare the survival time of T. gondii infected vs uninfected mar-
supials, the generalities described above apply, as does a lack of
validation in the diagnostic methodology used to infer host T. gondii
infection status from host serological data.
In addition to the two studies discussed above, Eymann et al.
(2006) trapped brushtail possums in various locations in Sydney,
on four different occasions over two and a half years. Trapped
possums had their T. gondii serological status measured using the
modiﬁed agglutination test, and were considered positive if react-
ing at a titre of 1:25. While this study did not aim to compare
survivability of infected vs uninfected hosts, and thus the use of
these data for such a purpose entails many limitations, it is of in-
terest that though 5/9 seropositive possums were not retrapped
subsequent to testing seropositive for T. gondii (55.6%; Jeffrey's 95%
CI 26.2e81.3%), the proportions of seronegative possums retrapped
were similar (varying from 43 to 65% over subsequent sessions).
3.2. Using morbidity and mortality linked to toxoplasmosis in
captive populations of Australian marsupials as an indicator of
outcomes of T. gondii infection in free-ranging populations
Relatively high morbidity and mortality rates have been re-
ported in outbreaks of toxoplasmosis (Miller et al., 1992; Barrows,
2006; Basso et al., 2007; Dubey and Crutchley, 2008) or likely
toxoplasmosis (Boorman et al., 1977; Jensen et al., 1985) in captive
populations involving a number of Australian marsupial species,
including sugar gliders, Bennett's wallabies, tammar wallabies
(Macropus eugenii), commonwallaroos, eastern grey kangaroos, red
kangaroos and long-nosed potoroos (Potorous tridactylus). How-
ever, these outbreaks, and case studies of toxoplasmosis in captive
marsupials, cannot be presumed to be representative of morbidity
and mortality rates following T. gondii infection in free-ranging
populations. Thus, they cannot be presumed to be indicative of
marsupial species' inherent susceptibility to T. gondii infection or to
toxoplasmosis, despite widespread citations of such studies to
these ends in the literature (e.g., Miller et al., 1992; Reddacliff et al.,
1993; Miller et al., 2003; Hartley and English, 2005; Barrows, 2006;
Bermudez et al., 2009; de la Cruz-Hernandez et al., 2012).
Firstly, cases of subclinical T. gondii infection in captive pop-
ulations are likely to go unnoticed, and hence uninvestigated and
unpublished. This may lead to an inaccurate preconception that
T. gondii infections typically manifest as clinical disease. Seroposi-
tive marsupials have been identiﬁed amongst captive populationsnot showing clinical signs of toxoplasmosis (Riemann et al., 1974;
Jakob-Hoff and Dunsmore, 1983; Miller et al., 2000; de Camps
et al., 2008) and subclinical infection consistent with T. gondii (not
conﬁrmed by further testing) has been demonstrated histopatho-
logically in captive dasyurids (Attwood et al., 1975). Secondly, a
substantial number of factors that may be associated with T. gondii
morbidity and mortality may differ between captive and free-
ranging populations of Australian marsupial species. These may
include differences in: stress-induced immunosuppression (for
example, as a result of housing circumstances, population density,
nutrition and interaction with humans); average life expectancy
(captive populations may include substantially older animals than
would be found in the wild); the presence of co-morbidities in
captive populations that may compromise an animal's immunity
(and predispose the animal to clinical toxoplasmosis) but would
rarely be compatible with survival in the wild; and mechanisms of
exposure to T. gondii (particularly via dietary sources, including
levels of infection and strains of T. gondii present in meat products
that are unlikely to be common in diets of free-ranging Australian
marsupials). These factors may substantially bias pertinent statis-
tics, such as morbidity and mortality rates following T. gondii
infection and/or the rate of recrudescence of latent infection to
clinical disease.
3.3. Using morbidity and mortality in experimental T. gondii
infection of Australian marsupial species under laboratory
conditions as an indicator of outcomes of T. gondii infection in free-
ranging populations
Experimental studies under laboratory conditions are very
useful for investigating the pathological processes of T. gondii
infection and clinical toxoplasmosis in Australian marsupial spe-
cies, and evaluating diagnostic methods. However, caution is
required in extrapolatingmorbidity andmortality rates observed in
such studies to free-ranging populations. For example, experi-
mental infections undertaken in eastern barred bandicoots
demonstrated the ability of T. gondii to cause fatal disease in this
species (2/2 infected bandicoots died) (Bettiol et al., 2000). These
ﬁndings may reﬂect eastern barred bandicoots being particularly
susceptible to fatal toxoplasmosis following T. gondii infection.
However, the widespread citation of this study as providing
conclusive evidence of the high susceptibility of Australian
marsupial species to toxoplasmosis is premature, for several
reasons.
Firstly, the study was restricted to eastern barred bandicoots,
and thus assumptions that the results are applicable to all Austra-
lian marsupial species are not appropriate. Secondly, the small
number of bandicoots infected is marked limitation in using the
ﬁndings of this study to estimate the morbidity and mortality rates
of toxoplasmosis post infection in this species. Thirdly, the inocu-
lation dose and strain of T. gondii used in the experiment may not
reﬂect the typical dose of infection, and virulence and pathoge-
nicity, of the strains of T. gondii to which free-ranging populations
of Australian marsupial species are commonly exposed. The ban-
dicoots were orally infected with 100 cysts of the P89 strain of
T. gondii, which is highly virulent in mice (Dubey et al., 1995). The
authors noted that a previous attempt to induce infection in ban-
dicoots with a lower dose of 10 oocysts of the same strain was
unsuccessful (Bettiol et al., 2000). Finally, the morbidity and mor-
tality rates observed in this study may have been biased by cir-
cumstances related to the experiment. In particular, the bandicoots
studied may have been under stress. They were captured from the
wild for the purposes of the study, then housed in captivity, fed a
novel diet, and subjected to handling and procedures which
included an oral inoculation procedure, repeated rectal
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immunosuppression does indeed act as a causal complement in
toxoplasmosis, stress may have facilitated the development of
clinical disease in these bandicoots.
Studies undertaken in marsupial populations habituated to
laboratory conditions prior to experimental infection may be more
accurate in estimating morbidity and mortality rates associated
with T. gondii infection in free-ranging populations, by moderating
the potential impact of stress. However, ﬁndings from such studies
vary. Experimental infections undertaken in four eastern grey
kangaroos, as part of a validation study for T. gondii serological tests,
did not result in clinical toxoplasmosis. Three kangaroos were
infected orally with the Pork I strain of T. gondii (5, 50 and 500
oocysts administered, respectively) and one kangaroo was infected
via intramuscular injection of 250 oocysts of the same strain. Three
of the four kangaroos seroconverted during the 48 days post
infection (the kangaroo dosed with 5 oocysts did not); none of the
kangaroos developed clinical signs of disease within this period
(Johnson et al., 1989). The interpretation of these results is limited,
however, by a lack of tests to conﬁrm the animals developed
infection post inoculation (eg histopathology or PCR of body tis-
sues). In contrast, in experimental infections of tammar wallabies,
undertaken as part of a vaccination trial, 7/9 wallabies orally dosed
with of 500 T. gondii oocysts (ME-49 strain) died 11e14 days post
infection; 1/1 wallabies dosed with 1000 T. gondii oocysts (ME-49
strain) orally died 12 days post infection; 1/1 wallabies dosed with
1000 T. gondii oocysts (PT-12 strain) orally died 15 days post
infection; and 1/1 wallabies dosed with 10 000 T. gondii oocysts
(PT-12 strain) orally died 9 days post infection (Reddacliff et al.,
1993). As part of another vaccination trial, six tammar wallabies
were dosed with the attenuated S48 strain of T. gondii intramus-
cularly (two with 62 000, two with 125 000, and two with 250 000
tachyzoites). Ten days after inoculation, both wallabies dosed with
125 000 tachyzoites and one wallaby dosed with 250 000 tachy-
zoites died acutely, and one wallaby dosed with 62 000 tachyzoites
was euthanized due to severe clinical illness. Post mortem ﬁndings
from all animals were indicative of toxoplasmosis. The remaining
two wallabies survived without clinical illness (Lynch et al., 1993).
The differences in the clinical outcome of infection between and
within these studies may reﬂect differences in: the virulence and
pathogenicity of the strains of T. gondii used in each study; the
T. gondii inoculation dose (two strains of T. gondii have been
demonstrated to have a dose-dependent pathogenicity in rats
(Dubey, 1996; De Champs et al., 1998)); the susceptibility of the
marsupial species studied to clinical toxoplasmosis (which may or
may not interact with T. gondii strain type or inoculation dose); or
stress-induced immunosuppression of the study subjects, possibly
due to inherent differences in the susceptibility of different
marsupial species to stress in captivity, or to differences in man-
agement practices between the experimental settings. Further, the
results of these studies cannot be conﬁdently extrapolated to
morbidity and mortality rates in free-ranging marsupial pop-
ulations, due to factors such as the small numbers of animals
infected, the potentially biasing inﬂuences of captivity, and inocu-
lation doses and strains of T. gondii infection which may not reﬂect
those commonly occurring in free-ranging marsupial populations.
4. Other possible effects of T. gondii infection that may
impact population viability of free-ranging Australian
marsupials
4.1. Possible inﬂuences of T. gondii on behaviour
In laboratory rats and mice, infection with T. gondii has been
shown to increase activity level and exploratory behaviour andreduce aversion to predator odour (eg Berdoy et al., 2000; Vyas
et al., 2007; Kannan et al., 2010). The ability to cause these
behavioural changes is considered to be an adaptation of the
parasite to increase transmission to the deﬁnitive host (McConkey
et al., 2013; Vyas, 2013). It has been suggested that similar behav-
ioural changes in infected marsupials may make them more
vulnerable to predation by exotic predators, such as foxes and cats
(Obendorf et al., 1996; Fancourt et al., 2014). Such extrapolation
should be treated cautiously, however; Worth et al. (2013, 2014)
document many exceptions to the commonly reported behav-
ioural effects of T. gondii infection in laboratory rodents, which they
suggest are due to the use of different T. gondii strains, different host
species and sexes, and different methodologies to measure
behaviour.
Before it can be conﬁdently asserted that infectionwith T. gondii
causes behavioural changes that may increase predation risk in
marsupial hosts, data from detailed behavioural studies on these
hosts are required. To date, such data have not been obtained. An
experimental study found infected eastern barred bandicoots were
more likely to be outside their nest boxes during daylight hours,
from 10 days post infection (Bettiol et al., 2000). However, the
sample size was too small to conﬁdently exclude chance effects or
ensure randomisation achieved control of confounding. Addition-
ally, measurement error and observer bias cannot be ruled out, as
the method of measurement and whether observers were blinded
in making these observations were not reported. Another study
found T. gondii seroprevalence to be higher in roadkill pademelons
than in culled pademelons, possibly indicating slower reaction
times. However, this may have been a chance ﬁnding resulting from
the small roadkill sample size (Hollings et al., 2013).
4.2. Possible effects of T. gondii infection on marsupial reproductive
success
From what is known of T. gondii infection in other species,
offspring survival could be inﬂuenced by vertical transmission of
the parasite. Alternatively, effects of the parasite on the reproduc-
tive ﬁtness of mature marsupials could inﬂuence the success of
breeding.
Available evidence strongly suggests that vertical transmission
of T. gondii infection can occur in black-faced kangaroos (Macropus
fuliginosus melanops), western grey kangaroos and woylies (Dubey
et al., 1988; Parameswaran et al., 2009b). Vertical transmission of
T. gondii from chronically infected western grey kangaroo dams to
their young may occur commonly: two out of nine (22.2%; Jeffrey's
95% CI 6.7e55.6%) pouch young of chronically infected dams were
positive for T. gondii via PCR (Parameswaran et al., 2009b). No study
has investigated the impacts of infection on the survival of verti-
cally infected young. If vertical transmission does occur relatively
frequently, and commonly results in adverse impacts on the health
of infected young, reproductive success in an infected population
may be compromised.
Reproductive success of mature marsupials associated with
T. gondii infection has been investigated in one study, of eastern
quolls (Fancourt et al., 2014). The mean number of pouch young in
JulyeSeptember was higher in females that were seropositive for
T. gondii, than those that were seronegative. Similarly, testicular
volume during the mating seasonwas higher in seropositive males,
although the implications of this ﬁnding is unclear as a relationship
between testicular volume and reproductive capacity in quolls has
not been demonstrated. In addition, there were difﬁculties in
accurately measuring and controlling for putative confounding
variables, which complicates interpretation of the data (Fancourt
et al., 2014). Anecdotally, high prevalence of T. gondii was
observed in populations of western grey kangaroos, red kangaroos
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(Parameswaran et al., 2010; Pan et al., 2012). While this suggests
that T. gondii infection does not substantially impact reproductive
capacity in these species, more speciﬁc investigations are required.5. Conclusions
T. gondii may be an important factor in population declines of
marsupial species in Australia. However, this remains a hypothesis,
as scientiﬁcally robust supporting evidence is not yet sufﬁcient to
draw any conclusions. Further research into this area in free-
ranging populations of marsupials is required. Such research
should consider:
1) Validation of diagnostic test(s) used to detect the presence or
absence of T. gondii infection in the species under study, to
enable consideration of potential impacts of misclassiﬁcation on
analytical study ﬁndings (Boadella et al., 2011). Validation of
tests in various marsupial species would also help to retro-
spectively clarify previous research ﬁndings.
2) The impact of sample sizes on results-ideally planning and un-
dertaking studies where an adequate sample size for statistical
extrapolations to a population level is realistically achievable, or
where the novelty of descriptive ﬁndings would justify a study
of only descriptive value. Measures of sampling error/precision
should be included in results and considered in the interpreta-
tion of study ﬁndings if making analytical inferences (O'Brien
et al., 2009; Boadella et al., 2011).
3) Sampling strategies, in an attempt to minimise the potential
inﬂuence of selection bias (Nusser et al., 2008; Anderson, 2001;
Boadella et al., 2011). Proportionate sampling is ideal, though
often not realistically achievable in observational studies of
wildlife.
4) Performing studies that involve temporal sequence on the same
individuals (cohort studies), to compare morbidity and mortal-
ity rates of T. gondii infected vs non infected animals in free-
ranging populations. Studies comparing ﬁndings in both stable
populations and populations subject to stressors (such as
habitat fragmentation) would be valuable in investigating the
possibility of interaction between stressors and the impact of
T. gondii infection on population health.
5) Controlling for confounding variables when making statistical
extrapolations (for example, controlling for sex and age if using
a Poisson regression to compare survivability of T. gondii infec-
ted and uninfected hosts). In most marsupial species, further
research aimed at identifying and validating measures of po-
tential confounders-particularly age-is required.
6) Potential inﬂuences of data clustering, which is potentially
common in wildlife studies but rarely considered when making
analytical inferences.Acknowledgements
The authors gratefully acknowledge the IJP PAW reviewers and
editor, who provided valuable feedback in the preparation of this
manuscript. This project was supported by The Holsworth Wildlife
Research Endowment-Equity Trustees Charitable Foundation. A.H
was supported by an Australian Postgraduate Award.Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.ijppaw.2015.12.002.References
Abbott, I., 2006. Mammalian faunal collapse in Western Australia, 1875-1925: the
hypothesised role of epizootic disease and a conceptual model of its origin,
introduction, transmission and spread. Aust. Zool. 33, 530e561.
Adkesson, M., Gorman, M., Hsaio, V., Whittington, J., Langan, J., 2007. Toxoplasma
gondii inclusions in peripheral blood leukocytes of a red-necked wallaby
(Macropus rufogriseus). Vet. Clin. Pathol. 36, 97e100.
Anderson, D.R., 2001. The need to get the basics right in wildlife ﬁeld studies. Wildl.
Soc. Bull. 29, 1294e1297.
Attwood, H., Woolley, P., 1973. Spontaneous malignant neoplasms in dasyurid
marsupials. J. Comp. Pathol. 83, 569e581.
Attwood, H., Woolley, P., Rickard, M., 1975. Toxoplasmosis in dasyurid marsupials.
J. Wildl. Dis. 11, 543e551.
Barnes, T., Goldizen, A., Morton, J., Coleman, G., 2010. Parasites of the brush-tailed
rock wallaby (Petrogale penicillata). J. Wildl. Dis. 46, 218e228.
Barrows, M., 2006. Toxoplasmosis in a colony of sugar gliders (Petaurus breviceps).
Vet. Clin. Exot. Anim. 9, 617e623.
Basso, W., Venturini, M.C., More, G., Quiroga, A., Bacigalupe, D., Unzaga, J.M.,
Larsen, A., Laplace, R., Venturini, L., 2007. Toxoplasmosis in captive Bennett's
wallabies (Macropus rufogriseus) in Argentina. Vet. Parasitol. 144, 157e161.
Boadella, M., Gortazar, C., Acevedo, P., Carta, T., Martin-Hernando, M.P., de la
Fuente, J., Vicente, J., 2011. Six recommendations for improving monitoring of
diseases shared with wildlife: examples regarding mycobacterial infections in
Spain. Eur. J. Wildl. Res. 57, 697e706.
Berdoy, M., Webster, J., Macdonald, D., 2000. Fatal attraction in rats infected with
Toxoplasma gondii. Proc. R. Soc. B 267, 1591e1594.
Bermúdez, R., Faílde, L.D., Losada, A.P., Nieto, J.M., Quiroga, M.I., 2009. Toxoplas-
mosis in Bennett's wallabies (Macropus rufogriseus) in Spain. Vet. Parasitol. 160,
155e158.
Bettiol, S., Obendorf, D., Nowarkowski, M., Goldsmid, J., 2000. Pathology of exper-
imental toxoplasmosis in eastern barred bandicoots in Tasmania. J. Wildl. Dis.
36, 141e144.
Boorman, G., Kollias, G., Taylor, R., 1977. An outbreak of toxoplasmosis in wallaroos
(Marcopus robustus) in a California zoo. J. Wildl. Dis. 13, 64e67.
Burbidge, A.A., McKenzie, N.L., Brennan, K.E.C., Woinarski, J.C.Z., Dickman, C.R.,
Baynes, A., Gordon, G., Menkhorst, P.W., Robinson, A.C., 2009. Conservation
status and biogeography of Australia's terrestrial mammals. Aust. J. Zool. 56,
411e422.
Burg, J., Grover, C., Pouletty, P., Boothroyd, J., 1989. Direct and sensitive detection of
a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.
J. Clin. Microbiol. 27, 1787e1792.
Canﬁeld, P., Hartley, W., Dubey, J., 1990. Lesions of toxoplasmosis in Australian
marsupials. J. Comp. Pathol. 103, 159e167.
Clarke, J., 2011. Translocation Outcomes for the Western Ringtail Possum (Pseu-
docheirus occidentalis) in the Presence of the Common Brushtail Possum (Tri-
chosurus vulpecula): Health, Survivorship and Habitat Use. PhD thesis. Murdoch
University, Perth.
Cook, I., Pope, J., 1959. Toxoplasma in Queensland, III: a preliminary survey of animal
hosts. Aust. J. Exp. Biol. Med. Sci. 37, 253e262.
de Camps, S., Dubey, J., Saville, W., 2008. Seroepidemiology of Toxoplasma gondii in
zoo animals in selected zoos in the midwestern United States. J. Parasitol. 94,
648e653.
De Champs, C., Pelloux, H., Dechelotte, P., Giraud, J., Bally, N., Ambroise-Thomas, P.,
1998. Toxoplasma gondii infection in rats by the RH strain: inoculum and age
effects. Parasite 5, 215e218.
de la Cruz-Hernandez, N., Carvajal-de la Fuente, V., Flores-Gutierrez, G., 2012.
Toxoplasmosis in captive eastern grey kangaroos (Macropus giganteus). J. Anim.
Vet. Adv. 11, 1780e1783.
Denny, E., Dickman, C., 2010. Review of Cat Management and Ecology Strategies in
Australia. Institute of Wildlife Research, University of Sydney, Sydney.
Dickman, C., 1996. Overview of the Impacts of Feral Cats on Australian Native Fauna.
Australian Nature Conservation Agency, Canberra.
Dubey, J., Ott-Joslin, J., Torgerson, R.W., Topper, M.J., Sundberg, J.P., 1988. Toxo-
plasmosis in black-faced kangaroos (Macropus fuliginosus melanops). Vet. Par-
asitol. 30, 97e105.
Dubey, J., Thulliez, P., Powell, E., 1995. Toxoplasma gondii in Iowa sows: comparison
of antibody titers to isolation of T. gondii by bioassays in mice and cats.
J. Parasitol. 81, 48e53.
Dubey, J., 1996. Pathogenicity and infectivity of Toxoplasma gondii oocysts for rats.
J. Parasitol. 82, 951e956.
Dubey, J., 1998. Advances in the lifecycle of Toxoplasma gondii. Int. J. Parasitol. 28,
1019e1024.
Dubey, J., Crutchley, C., 2008. Toxoplasmosis in wallabies (Macropus rufogriseus and
Macropus eugenii): blindness, treatment with atovaquone, and isolation of
Toxoplasma gondii. J. Parasitol. 94, 929e933.
Dubey, J., Lindsay, D., Lappin, M., 2009. Toxoplasmosis and other intestinal coccidial
infections in cats and dogs. Vet. Clin. N. Am. Small 39, 1009e1034.
Dubey, J., 2010. Toxoplasmosis of Animals and Humans, second ed. CRC Press, Boca
Raton.
Ebert, D., Herre, E., 1996. The evolution of parasitic diseases. Parasitol. Today 12,
96e101.
Eymann, J., Herbert, C., Cooper, D., Dubey, J., 2006. Serological survey for Toxoplasma
gondii and Neospora caninum in the common brushtail possum (Trichosurus
A.E. Hillman et al. / International Journal for Parasitology: Parasites and Wildlife 5 (2016) 17e27 27vulpecula) from urban Sydney, Australia. J. Parasitol. 92, 267e272.
Fancourt, B., Nicol, S.C., Hawkins, C.E., Jones, M.E., Johnson, C.N., 2014. Beyond the
disease: Is Toxoplasma gondii infection causing population declines in the
eastern quoll (Dasyurus viverrinus)? Int. J. Parasitol. Parasites Wildl. 3, 102e112.
Fisher, D., Blomberg, S., Owes, I., 2003. Extrinsic versus intrinsic factors in the
decline and extinction of Australian marsupials. Proc. R. Soc. Lond. 270,
1801e1808.
Freeland, W., 1994. Parasites, pathogens and the impacts of introduced organisms
on the balance of nature in Australia. In: Moritz, C., Kikkawa, J. (Eds.), Conser-
vation Biology in Australia and Oceania. Surrey Beatty, Sydney, pp. 171e180.
Gibb, D., Kakulas, B., Perret, D., Jenkyn, D., 1966. Toxoplasmosis in the Rottnest
quokka (Setonix brachyurus). Aust. J. Exp. Biol. Med. Sci. 44, 665e672.
Haigh, A., Gaynor, W., Morris, K., 1994. A health monitoring program for captive,
wild and translocated chuditch (Dasyurus geoffroii). Proc. Conf. Aust. Assoc. Vet.
Cons. Biol. 52e66.
Hartley, M., English, A., 2005. A seroprevalence survey of Toxoplasma gondii anti-
body in common wombats (Vombatus ursinus). Eur. J. Wildl. Res. 51, 65e67.
Hill, N.J., Dubey, J.P., Vogelnest, L., Power, M.L., Deane, E.M., 2008. Do free ranging
common brushtail posums (Trichosurus vulpecula) play a role in the trans-
mission of Toxoplasma gondii within a zoo environment? Vet. Parasitol. 152,
202e209.
Hollings, T., Jones, M., Mooney, N., McCallum, H., 2013. Wildlife disease ecology in
changing landscapes: mesopredator release and toxoplasmosis. Int. J. Parasitol.
Parasites Wildl. 2, 110e118.
Jakob-Hoff, R., Dunsmore, J., 1983. Epidemiological aspects of toxoplasmosis in
southern Western Australia. Aust. Vet. J. 60, 217e218.
Jensen, J., Patton, S., Wright, B., Loefﬂer, D., 1985. Toxoplasmosis in marsupials in a
zoological collection. J. Zoo Anim. Med. 16, 129e131.
Johnson, A., Roberts, H., Munday, B., 1988. Prevalence of Toxoplasma gondii antibody
in wild macropods. Aust. Vet. J. 65, 199e201.
Johnson, A., Roberts, H., Statham, P., Munday, B., 1989. Serodiagnosis of acute
toxoplasmosis in macropods. Vet. Parasitol. 34, 25e33.
Kannan, G., Moldovan, K., Xiao, J., Yolken, R.H., Jones-Brando, L., Pletnikov, M.V.,
2010. Toxoplasma gondii strain dependent effects on mouse behaviour. Folia
Parasitol. 57, 151e155.
Lappin, M.R., Dawe, D.L., Lindl, P.A., Greene, C.E., Prestwood, A.K., 1991. The effect of
glucocorticoid administration on oocyst shedding, serology, and cell-mediated
immune responses of cats with acute or chronic toxoplasmosis. J. Am. Anim.
Hosp. Assoc. 27, 625e632.
Lynch, M., Obendorf, D., Reddacliff, G., 1993. Serological responses of tammar
wallabies (Macropus eugenii) to inoculation with an attenuated strain of Toxo-
plasma gondii. Proc. Am. Assoc. Zoo Vet.
McConkey, G.A., Martin, H., Bristow, G., Webster, J.P., 2013. Toxoplasma gondii
infection and behavioure location, location, location? J. Exp. Biol. 216, 113e119.
McKenzie, N.L., Burbidge, A.A., Baynes, A., Brereton, R.N., Dickman, C.R., Gordon, G.,
Gibson, L.A., Menkhorst, P.W., Robinson, A.A., Williams, M.R., Woinarski, J.C.Z.,
2007. Analysis of factors implicated in the recent decline of Australia's mammal
fauna. J. Biogeogr. 34, 597e611.
Miller, D., Mitchell, G.F., Biggs, B., McCracken, H., Myroniuk, P., Hewish, M., 2000.
Agglutinating antibodies to Toxoplasma gondii in sera from captive eastern
barred bandicoots in Australia. J. Wildl. Dis. 36, 213.
Miller, D., Faulkner, C., Patton, S., 2003. Detection of Toxoplasma gondii IgG anti-
bodies in juvenile great grey kangaroos, Macropus giganteus giganteus. J. Zoo
Wildl. Med. 34, 189e193.
Miller, M., Ehlers, K., Dubey, J., Van Steenbergh, K., 1992. Outbreak of toxoplasmosis
in wallabies on an exotic animal farm. J. Vet. Diagn. Investig. 4, 480.
Montoya, J., Leisenfeld, O., 2004. Toxoplasmosis. Lancet 363, 1965e1976.
Munday, B., 1972. A serological study of some infectious diseases of Tasmanian
wildlife. J. Wildl. Dis. 8, 169e175.
Nicoll, S., Wright, S., Maley, S.W., Burns, S., Buxton, D., 1997. A mouse model of
recrudescence of Toxoplasma gondii infection. J. Med. Microbiol. 46, 263e266.
Nusser, S.M., Clark, W.R., Otis, D.L., Huang, L., 2008. Sampling considerations for
disease surveillance in wildlife populations. J. Wildl. Manag. 72, 52e60.
Oakwood, M., Pritchard, D., 1999. Little evidence of toxoplasmosis in a declining
species, the northern quoll (Dasyurus hallucatus). Wildl. Res. 26, 329e333.
Obendorf, D., Munday, B., 1983. Toxoplasmosis in wild Tasmanian wallabies. Aust.Vet. J. 60, 62.
Obendorf, D., Statham, P., Driessen, M., 1996. Detection of agglutinating antibodies
to Toxoplasma gondii in sera from free-ranging eastern barred bandicoots
(Perameles gunnii). J. Wildl. Dis. 32, 623e626.
O'Brien, C., van Riper, C., Myers, D.E., 2009. Making reliable decisions in the study of
wildlife diseases: using hypothesis tests, statistical power, and observed effects.
J. Wildl. Dis. 45, 700e712.
O'Callaghan, M., Moore, E., 1986. Parasites and serological survey of common
brushtail possums (Trichosurus vulpecula) from Kangaroo Island, South
Australia. J. Wildl. Dis. 22, 589e591.
Pan, S., Thompson, R.C.A., Grigg, M.E., Sundar, N., Smith, A., Lymbery, A.J., 2012.
Western Australian marsupials are multiply infected with genetically diverse
strains of Toxoplasma gondii. PLoS One 7, e45147.
Parameswaran, N., 2008. Toxoplasma gondii in Australian Marsupials. PhD Thesis.
Murdoch University, Perth.
Parameswaran, N., O'Handley, R.M., Grigg, M.E., Fenwick, S.G., Thompson, R.C.A.,
2009a. Seroprevalence of Toxoplasma gondii in wild kangaroos using an ELISA.
Parasitol. Int. 58, 161e165.
Parameswaran, N., O'Handley, R.M., Grigg, M.E., Wayne, A., Thompson, R.C.A.,
2009b. Vertical transmission of Toxoplasma gondii in Australian marsupials.
Parasitol 136, 939e944.
Parameswaran, N., Thompson, R.C.A., Sundar, N., Pan, S., Johnson, M., Smith, N.C.,
Grigg, M.E., 2010. Nonarchetypal type II-like and atypical strains of Toxoplasma
gondii infecting marsupials of Australia. Int. J. Parasitol. 40, 635e640.
Piergili Fioretti, D., 2004. Problems and limitations of conventional and innovative
methods for the diagnosis of toxoplasmosis in humans and animals. Para-
ssitologia 46, 177e181.
Pope, J., Bicks, V., Cook, I., 1957a. Toxoplasma in Queensland II: natural infections in
bandicoots and rats. Aust. J. Exp. Biol. Med. Sci. 35, 481.
Pope, J., Derrick, E., Cook, I., 1957b. Toxoplasma in Queensland I: observations on a
strain of Toxoplasma gondii isolated from a bandicoot, Thylacis obesulus. Aust. J.
Exp. Biol. Med. 35, 481e490.
Reddacliff, G., Hartley, W., Dubey, J., Cooper, D., 1993. Pathology of experimentally-
induced, acute toxoplasmosis in macropods. Aust. Vet. J. 70, 4e6.
Riemann, H., Behymer, D.E., Fowler, M.E., Schulz, T., Lock, A., Orthoefer, J.G.,
Silverman, S., Franti, C.E., 1974. Prevalence of antibodies to Toxoplasma gondii in
captive exotic mammals. J. Am. Vet. Med. Assoc. 165, 798e800.
Ruskin, J., Remington, J., 1976. Toxoplasmosis in the compromised host. Ann. Intern.
Med. 2, 193e199.
Saunders, G., Gentle, M., Dickman, C., 2010. The impacts and management of foxes
(Vulpes vulpes) in Australia. Mamm. Rev. 40, 181e211.
Skerratt, L., Phelan, J., McFarlane, R., Speare, R., 1997. Serodiagnosis of toxoplasmosis
in a common wombat. J. Wildl. Dis. 33, 346e351.
Smith, I., Munday, B., 1965. Observations on the incidence of Toxoplasma gondii in
native and introduced feral fauna in eastern Australia. Aust. Vet. J. 41, 285e286.
Su, C., Shwab, E.K., Zhou, P., Zhu, X.Q., Dubey, J.P., 2010. Moving towards an inte-
grated approach to molecular detection and identiﬁcation of Toxoplasma gondii.
Parasitology 137, 1e11.
Thompson, R., Lymbery, A., Smith, A., 2010. Parasites, emerging disease and wildlife
conservation. Int. J. Parasitol. 40, 1163e1170.
Turni, C., Smales, L., 2001. Parasites of the bridled nailtail wallaby (Onychogalea
fraenata) (Marsupilia: Macropodidae). Wildl. Res. 28, 403e411.
Vyas, A., Kim, S., Sapolsky, R., 2007. The effects of Toxoplasma infection on rodent
behavior are dependent on dose of the stimulus. Neuroscience 148, 342e348.
Vyas, A., 2013. Parasite-augmented mate choice and reduction in innate fear in rats
infected by Toxoplasma gondii. J. Exp. Biol. 216, 120e126.
Wilhelmsen, C., Montali, R., 1980. Toxoplasmosis in a parma wallaby. Proc. Am.
Assoc. Zoo Vet. 141e143.
Woinarski, J.C.Z., 2015. Critical-weight-range marsupials in northern Australia are
declining: a commentary on Fisher et al. (2014) ‘The current decline of tropical
marsupials in Australia: is history repeating?’. Glob. Ecol. Biogeogr. 24, 118e122.
Worth, A., Lymbery, A., Thompson, R., 2013. Adaptive host manipulation of Toxo-
plasma gondii: fact or ﬁction? Trends Parasitol. 29, 150e155.
Worth, A., Thompson, R., Lymbery, A., 2014. Reevaluating the evidence for Toxo-
plasma gondii-induced behavioural changes in rodents. Adv. Parasitol. 85,
109e142.
